Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Noloon Oct 20, 2019 1:51pm
156 Views
Post# 30248875

RE:We can't be sure that Q3 numbers will show major improvement

RE:We can't be sure that Q3 numbers will show major improvementWell, there has to be some progress in Q3 if we hold Tripp accountable for his words. In the InvestorIntel video, which was posted online on August 29th (right into Q3), Tripp says at 1:44 'It's starting to really ramp up in terms of where sales and revenue are...'

So, if things started to 'really ramp up' in Q3, that means that something has happened and we should not see 1600 tests and a copied/pasted text from the previous Q used for the next one. 'Ramp up' means positive progression to me. Not stagnancy. So, this sentence was used in a video meant not only for present investors but also future ones. I can't imagine him lying about that in such a way. That would be foolish. The video did not have much visibility but Tripp did not know that at the moment of the recording. So, the best move for him, at that precise moment, would have been to tell the truth.

So, with that in mind, the next results are going to be very important for me. Not only in terms of numbers but also in terms of integrity from management. Things are ramping up or they are not. If they are not, one should not use these words. Is there any other way to interpret this?

November will be a pivotal moment for me and my SZLS investment. 
Bullboard Posts